The role of the subpopulations of dendritic cells in psoriasis;Znaczenie subpopulacji komórek dendrytycznych w patogenezie łuszczycy

Postepy Dermatologii i Alergologii

Volumn 24, Issue 6, 2007, Pages 263-270

  Nedoszytko, Bogusław ^a   Roszkiewicz, Jadwiga ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Dendritic cells; Pathogenesis; Psoriasis

Indexed keywords

ALPHA INTERFERON; HEAT SHOCK PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 2; INTERLEUKIN 23; TUMOR NECROSIS FACTOR;

CELL COUNT; CELL FUNCTION; CELL MIGRATION; CELL SUBPOPULATION; CYTOKINE PRODUCTION; DENDRITIC CELL; EFFECTOR CELL; ENZYME SYNTHESIS; EPIDERMIS CELL; HUMAN; LANGERHANS CELL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; LYMPHOID CELL; MOLECULAR RECOGNITION; NATURAL KILLER CELL; PATHOGENESIS; PSORIASIS; REVIEW; SKIN CELL; SKIN DEFECT; SKIN INFLAMMATION; TH1 CELL;

EID: 38349114549     PISSN: 1642395X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (56)

1. Bos JD, de Rie MA, Teunissen MB, Piskin G. Psoriasis: dysregulation of innate immunity. Br J Dermatol 2005; 152: 1098-107.
2. Gaspari AA. Innate and adaptive immunity and the pathophysiology of psoriasis. J Am Acad Dermatol 2006; 54 (Suppl. 2): S67-80.
3. Lowes MA, Bowcock AM, Krueger JG. Pathogenesis and therapy of psoriasis. Nature 2007; 445: 866-73.
4. Van der Kerkhof PC. The evolution of psoriatic lesion. Br J Dermatol 2007; 157: 4-15.
5. Rutella S, Lemoli RM. Regulatory T cells and tolerogenic dendritic cells: from basic biology to clinical applications. Immunol Lett 2004; 94: 11-26.
6. Romani N, Ebner S, Tripp CH, et al. Epidermal langerhans cells - changing views on their function in vivo. Immunol Lett 2006; 106: 119-25.
7. Valadeau J, Saeland S. Cutaneous dendritic cells. Semin Immunol 2005; 17: 273-83.
8. Guttman-Yassky E, Lowes M, Fuentes-Duculan J, et al. Major differences in inflammatory dendritic cells and their products distinguish atopic dermatitis from psoriasis. J Allergy Clin Immunol 2007; 119: 1210-7.
9. Dieu MC, Vanbervliet B, Vicari A, et al. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J Ex Med 1998; 188: 373-86.
10. Liu Y, Krueger JG, Bowcock AM. Psoriasis: genetic associations and immune system changes. Genes Immun 2007; 8: 1-12.
11. Nickoloff BJ, Bonish BK, Marble DJ, et al. Lessons learned from psoriatic plaques concerning mechanisms of tissue repair, remodeling, and inflammation. J Investig Dermatol Symp Proc 2006; 11: 16-29.
12. Allam JP, Nowak N. The pathology of atopic eczema. Clin Exp Dermatol 2005; 31: 89-93.
13. Beissert S, Schwartz A, Schwartz T. Regulatory T-cells. J Invest Dermatol 2006; 126: 15-24.
14. Wollenberg A, Wagner M, Gönther S, et al. Plasmacytoid dendritic cells: a new cutaneous dendritic cell subset with distinct role in inflammatory skin diseases. J Invest Dermatol 2002; 119: 1096-102.
15. Dzionek A, Inagaki Y, Okawa K, et al. Plasmacytoid dendritic cells: from specific surface markers to specific cellular functions. Hum Immunol 2002; 63: 1133-48.
16. McKenna K, Beignon AS, Bhardway N. Plasmacytoid dendritic cells: linking innate and adoptive immunity. J Virol 2005; 79: 17-27.
17. Rissoan MC, Soumelis V, Kadowaki N, et al. Reciprocal control ofT helper cell and dendritic cell differentiation. Science 1999; 283: 1183-6.
18. Nestle FO, Zheng XG, Thompson CB, et al. Characterization of dermal dendritic cells obtained from normal human skin reveals phenotypic and functionally distinctive subsets. J Immunol 1993; 151: 6535-45.
19. Pogorzelska-Dyrbuś J, Pogorzelska-Antkowiak A, Hadas E. Rola komórek Langerhansa w układzie immunologicznym skóry. Przeglaa̧d Dermatol 2004; 91: 147-52.
20. Nickoloff BJ. Cutaneous dendritic cells in the crossfire between innate and adaptive immunity. J Dermatol Sci 2002; 29: 159-65.
21. Blomberg S, Eloranta ML, Magnusson M, et al. Expression of the marker BDCA-2 and BDCA-4 and production of interferon-alpha by plasmacytoid dendritic cells in systemic lupus erythematosus. Arthritis Rheum 2003; 48: 2524-32.
22. Hashizume H, Horibe T, Yagi H, et al. Compartmental imbalance and aberrant immune function of blood CD123+ (plasmacytoid) and CD11c+ (myeloid) dendritic cells in atopic dermatitis. J Immunol 2005; 174: 2396-403.
23. Majewski S. Układ odpornościowy skóry. W: Immunologia. Gołşb J, Jakubisiak M, Lasek W (red.). PWN, Warszawa 2002; 303-13.
24. Deguchi M, Aiba S, Ohtani H, et al. Comparison of the distribution and numbers of antigen-presenting cells among T-lymphocyte-mediated dermatoses: CD1a+, factor XIIIa+, and CD68+ cells in eczematous dermatitis, psoriasis, lichen planus and graft-versus-host disease. Arch Dermatol Res 2002; 294: 297-302.
25. Lowes MA, Chamian F, Abello MV, et al. Increase in TNF-alpha and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a). Proc Natl Acad Sci USA 2005; 27: 19057-62.
26. Nickoloff BJ, Nestle FO. Recent insight into the immunopathogenesis of psoriasis provide new therapeutic opportunities. J Clin Invest 2004; 113: 1664-75.
27. Immunologia. Goła̧b J, Jakubisiak M, Lasek W (red.). PWN, Warszawa 2002.
28. Curry JL, Qin JZ, Bonish B, et al. Innate immune related receptors in normal and psoriatic skin. Arch Pathol Lab Med 2003; 127: 178-86.
29. Kang SS, Kauls LS, Gaspari AA. Toll-like receptors: applications to dermatologic disease. J Am Acad Dermatol 2006; 54: 951-83.
30. Nestle FO, Conrad C, Tun-Kyi A, et al. Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production. J Exp Med 2005; 202: 135-43.
31. Pietrzak A, Janowski K, Chodorowska G, et al. Plasma interleukin-18 and dendritic cells in males with psoriasis vulgaris. Mediators Inflamm 2007; 61254.
32. Cumberbatch M, Singh M, Dearman RJ, et al. Impaired Langerhans cell migration in psoriasis. J Exp Med 2006; 203: 953-60.
33. Cumberbatch M, Bhushan M, Dearman RJ, et al. IL-1beta-induced Langerhans' cell migration and TNF-alpha production in human skin: regulation by lactoferrin. Clin Exp Immunol 2003; 132: 352-9.
34. Wollenberg A, Kraft S, Hanau D, Bieber T. Immunomorphological and ultrastructural characterization of Langerhans cells and a novel, inflammatory dendritic epidermal cell (IDEC) population in lesional skin of atopic eczema. J Invest Dermatol 1996; 106: 446-53.
35. Wollenberg A, Haberstok J, Teichmann B, et al. Demonstration of the low-affinity IgE receptor Fc epsilonRII/CD23 in psoriatic epidermis: inflammatory dendritic epidermal cells (IDEC) but not Langerhans cells are the relevant CD1a-positive cell population. Arch Dermatol Res 1998; 290: 517-21.
36. Novak N, Allam JP, Hagemann T, et al. Characterization of FcepsilonRI-bearing CD123 blood dendritic cell antigen-2 plasmacytoid dendritic cells in atopic dermatitis. J Allergy Clin Immunol 2004; 114: 364-70.
37. Novak N, Bieber T. The role of dendritic cell subtypes in the pathophysiology of atopic dermatitis. J Am Acad Dermatol 2005; 53 (Suppl 2): S171-6.
38. Robinson SP, Patterson S, English N, et al. Human peripheral blood contains two distinct lineages of dendritic cells. Eur J Immunol 1999; 29: 2769-78.
39. Serbina NV, Salazar-Mather TP, Biron CA, et al. TNF/iNOS-producing dendritic cells mediate innate immune defence against bacterial infection. Immunity 2003; 19: 59-70.
40. Komine M, Karakawa M, Takekoshi T, et al. Early inflammatory changes in the "perilesional skin" of psoriatic plaques: is there interaction between dendritic cells and keratinocytes? J invest Dermatol 2007; 127: 1915-22.
41. Boyman O, Conrad C, Dudli C, et al. Activation of dendritic antigen-presenting cells expressing common heat shock protein receptor CD91 during induction of psoriasis. Br J Dermatol 2005; 152: 1211-8.
42. Chen J, Tan Z, Liu H, et al. Expression of plasmacytoid dendritic cells, IRF-7, IFN-alpha m-RNA in the lesions of psoriasis vulgaris. J Huazhong Univ Sci Technolog Med Sci 2006; 26: 747-9.
43. Nestle FO, Gilliet M. Defining upstream elements of psoriasis pathogenesis: an emerging role for interferon alpha. J Invest Dermatol 2005; 125: 14-5.
44. Nestle FO, Conrad C, Tun-Kyi A, et al. Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production. J Exp Med 2005; 202: 135-43.
45. Krug A, Towarowski A, Britsch S, et al. Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12. Eur J Immunol 2001; 31: 3026.
46. Giliet M, Conrad C, Geiges M, et al. Psoriasis trigerred by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors. Arch Dermatol 2004; 140: 1490-5.
47. Wu JK, Siller G, Strutton G. Psoriasis induced by topical imiquimod. Australas J Dermatol 2004; 45: 47-50.
48. Leung DY, et al. Bacterial superantigens induce T cell expression of the skin-selection homing receptor: the cutaneous lymphocyte-associated antigen via stimulation of intedeukin 12 production. J Exp Med 1995; 181: 747-53.
49. Gudjonsson JE, Johnston A, Sigmundsdottir H, Valdimarsson H. Immunopathogenetic mechanisms in psoriasis. Clin Exp Immunol 2004; 135: 1-8.
50. Watanabe N, Hanabuchi S, Marloie-Provost MA, et al. Human TSLP promotes CD40 ligand induced IL-12 production by myeloid dendritic cells but maintains their Th2 priming potential. Blood 2005; 105: 4749-51.
51. Zylicz M, Bocian K, Korczak-Kowalska G. Komórki regulatorowe: powstawanie, mechanizmy i efekty działania oraz mozliwe wykorzystanie w transplantologii. Post Hig Med Dośw 2005; 59: 160-71.
52. Sugiyama H, Gyulai R, Toichi E, et al. Dysfunctional blood and target tissue CD4+ CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation. J Immunol 2005; 174, 164-73.
53. 3. Blood 2005; 106: 3490-7.
54. Liu YJ. IPC: professional type I interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol 2005; 23: 275-306.
55. Homey B, Steinhoff M, Ruzicka T, Leung DY. Cytokines and chemokines orchestrate atopic skin inflammation. J Allergy Clin Immunol 2006; 118: 178-89.
56. Soumelis V, Reche PA, Kanzler H. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLE Nat Immunol 2002; 3: 673-80.